Antiphospholipid Antibodies in an in vivo Thrombosis Model in Mice

Harris EN Syndrome of the Black Swan. Br J Rheumatol 1987 ; 26: 324-6.

Asherson RA , Khamashta MA , Ordi-Ros J. et al. The 'primary' APS: major serological features. Medicine 1989; 68: 366-74.

Alarcon-Segovia D. , Sanchez-Guerrero J. Primary APS. J Rheumatol 1989; 16: 482-8.

Sammaritano LR , Gharavi AE , Lockshin MD Antiphospholipid Antibody syndrome: immunologic and clinical aspects. Semin Arth Rheum 1990 ; 20: 81-96.

Harris EN Annotation: antiphospholipid antibodies. Br J Haematol 1990; 74: 1-9.

Derksen Rhwm , deGroot P. , van Vliet M. et al. Antibodies to platelets in thrombocytopenic patients with anti-phospholipid antibodies . Arthritis Rheum 1990; 33: S163.

Triplett DA , Brandt JT , Kaczor D. et al. Laboratory diagnosis of lupus inhibitors: a comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure. Am J Clin Pathol 1983; 79: 678-82.

McNeil HP , Chesterman CN , Krilis SA Immunology and clinical importance of antiphospholipid antibodies . Adv Immunol 1991; 49: 193-280.

Harris EN , Gharavi AE , Tincani A. et al. Affinity purified anticardiolipin and anti-DNA antibodies. J Clin Lab Immunol 1985; 16: 1-6.

Pengo V. , Heine MJ , Thiagarajan P. et al. Immunological specificity and mechanism of action of IgG lupus anticoagulants. Blood 1987; 70: 69-76.

Galli M. , Bevers EM , Comfurius T. et al. Effect of antiphospholipid antibodies on procoagulant activity of activated platelets and platelet-derived microvesicles. Br J Haematol 1993 ; 83: 466-72.

Bevers EM , Galli M. , Barbui T. et al. Lupus anticoagulant (LA) IgGs are not directed to phospholipids only but to a complex lipid-bound human prothrombin. Thromb Haemost 1991; 66: 629-32.

Oosting JD , Derksen Rhwm , Entjes TI et al. Lupus anticoagulant activity is frequently dependent on the presence of β2-glycoprotein 1. Thromb Haemost 1992; 67: 499-502.

Fleck RA , Rapaport SE , Rao Lvm. Anti-prothrombin antibodies and the lupus anticoagulant. Blood 1988; 72: 512-19.

Roubey Ras , Pratt CW , Buyon JP et al. Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent on β2glycoprotein 1. J Clin Invest 1992; 90: 1100-4.

Pierangeli SS , Harris EN , Gharavi AE et al. Are immunoglobulins with lupus anticoagulant activity specific for phospholipids? Br J Haematol 1993; 85: 124-32.

Carreras LO , Machin SJ , Deman R. Arterial thrombi, intrauterine death and 'lupus anticoagulant': detection of immunoglobulin interfering with prostacyclin formation. Lancet 1981; i: 244-6.

Goldsmith GH , Pierangeli SS , Branch DW et al. Inhibition of prothrombin activation by antiphospholipid antibodies and β2 glycoprotein 1. Br J Haematol (in press).

Thiagarjan P. , Shapiro SS , DeMarco L. Monoclonal immunoglobulin M coagulation inhibitor with phospholipid specificity-mechanism of a lupus anticoagulant. J Clin Invest 1980; 66: 397-405.

Galli M. , Bevers EM , Comfurius T. et al. Effect of antiphospholipid antibodies on procoagulant activity of activated platelets and platelet-derived microvesicles. Br J Haematol 1993 ; 83: 466-72.

Brandt JT Assays for phospholipid-dependent formation of thrombin and factor Xa: a potential method for quantifying lupus anticoagulant activity. Thromb Haemost 1991; 66: 453-8.

Hasselaar P. , Derksen Rhwm , Blokzijl L. et al. Thrombosis associated with antiphospholipid antibodies cannot be explained by effects on endothelial and platelet prostanoid synthesis. Thromb Haemost 1988; 59: 80-5.

Walker TS , Triplett DA , Javed N. et al. Evaluation of lupus anticoagulants: antiphospholipid antibodies, endothelium associated immunoglobulin, endothelial prostacyclin secretion and antigenic protein S levels. Thromb Res 1988; 51: 267-71.

Rustin Mha , Bull HA , Machin SJ et al. Effects of the lupus anticoagulant in patients with systemic lupus erythematosus on endothelial cell prostacyclin release and procoagulant activity. J Invest Dermatol 1988; 90: 744-8.

Watson TS , Schorer AE Lupus anticoagulant inhibition of in vitro prostacyclin release is associated with a thrombosis-prone subset of patients. Am J Med 1991; 90: 47-53.

Vismara A. , Meroni PL , Tincani A. et al. Relationship between anticardiolipin and endothelial cell antibodies in systemic lupus erythematosus. Clin Exp Immunol 1988; 74: 247-52.

Rosenbaum J. , Potter BE , Woo P. et al. Measurement and characterization of circulating anti-endothelial cell IgG in connective tissue diseases. Clin Exp Immunol 1988; 72: 450-5.

LeRoux G. , Wautier MP , Guillevin L. et al. IgG binding to endothelial cells in systemic lupus erythematosus . Thromb Haemost 1986; 56: 144-8.

Branch DW , Rodgers GM Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism for thrombosis . Am J Obstet Gynecol 1993; 168: 206-10.

Comp PC , DeBault LE , Esmon NL et al. Human thrombomodulin is inhibited by IgG from two patients with non-specific anticoagulants. Blood 1983; 62: 299 (abstract).

Freyssinet JM , Wiesel ML , Gauchy J. et al. An IgM lupus anticoagulant that reutilizes the enhancing effect of phospholipid on purified thrombomodulin activity. A mechanism for thrombosis. Thromb Haemost 1986; 55: 309-13.

Cariou R. , Tobelin G. , Belluci S. et al. Effect of the lupus anticoagulant on antithrombogenic properties of endothelial cells: inhibition of thrombomodulin dependent protein C activation . Thromb Haemost 1985; 60: 54-8.

Khamashta MA , Harris EN , Gharavi AE et al. Immune mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes. Ann Rheum Dis 1988; 47: 849-54.

Out HJ , deGroot PG , van Vliet M. Antibodies to platelets in patients with antiphospholipid antibodies . Blood 1991; 77: 2655.

Schorer AE , Wickham Nwr , Watson KV Lupus anticoagulant induces a selective defect in thrombin-mediated endothelial prostacyclin release and platelet aggregation. Br J Haematol 1989; 71: 399-404.

Lellouche F. , Martinuzzo M. , Said P. et al. Imbalance of thromboxane/ prostacyclin biosynthesis in patients with lupus anticoagulant . Blood 1991 ; 78: 2894-9.

Lin Y-L. , Wang C-T. Activation of human platelets by the rabbit anticardiolipin antibodies . Blood 1992; 80: 3134-43.

Campbell AL , Pierangeli SS , Wellhausen S. et al. Autoimmune antiphospholipid antibodies enhance activation and aggregation of human platelet in vitro. Blood 1993; 82: 404 (abstract).

Gharavi AE Anti-phospholipid syndrome in murine lupus. In: Phospholipid Binding Antibodies. Harris EN , Exner T , Asherson RA , Hughes GRV (eds). Boca Raton: CRC Press, 1991: 403-16.

Branch WD , Dudley DJ , Mitchell MD et al. IgG fractions from patients with antiphospholipid antibodies cause fetal death in Balb/c mice: a model for autoimmune fetal loss. Am J Obstet Gynecol 1990; 163: 120.

Bakimer R. , Fishman P. , Blank M. et al. Induction of primary APS in mice by immunization with a human monoclonal antacardialipin antibody (H-3). J Clin Invest 1992; 89: 1558-63.

Blank M. , Cohen J. , Toder C. et al. Induction of APS in naive mice with mouse lupus monoclonal and human polyclonal anticardiolipin antibodies. Proc Natl Acad Sci (USA) 1991 ; 88: 3069-73.

Smith HR , Hansen CL , Rose R. et al. Autoimmune MRL-1 pr/lpr mice are an animal model for the secondary APS. J Rheumatol 1990; 17: 911-15.

Stockmans F. , Deckmyn H. , Gruwez J. et al. Continuous quantitative monitoring of mural thrombus kinetics in the crushed rat femoral vein. Thromb Haemost 1991; 65: 425.

Barker JH , Gu JM , Anderson GL et al. The effects of heparin and dietary fish oil on embolic events and the microcirculation downstream from a small artery repair. Plastic Reconstruct Surg 1993; 91: 335-42.

Pierangeli SS , Barker JH , Stikovic D. et al. Effect of human IgG antiphospholipid antibodies on an in vitro thrombosis model in mice. Thromb Haemost (in press).

Harris EN , Chan Jkh , Asherson RA et al. Thrombosis, recurrent fetal loss and thrombocytopenia. Predictive value of the anti-cardiolipin antibody test. Arch Interm Med 1986; 146: 2153-6.

Lechner K. , Pabinger-Fasching I. Lupus anticoagulant and thrombosis. A study of 25 cases and review of the literature. Haemostasis 1985; 15: 254-62.

Lockshin MD , Qamar T. , Levy RA et al. IgG but not IgM antiphospholipids antibody binding is temperature dependent. J Clin Immunol 1988; 8: 188-92.

Alving BM , Barr CF , Tank DB Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times. Am J Med 1990; 88: 122-16.

Gharavi AE , Harris EN , Asherson RA et al. IgG subclass and light chain distribution of anticardiolipin and anti-DNA antibodies in systemic lupus erythematosus. Ann Rheum Dis 1988; 47: 286-90.

Weidman CE , Wallace DJ , Peter JB Studies of IgG, IgM and IgA antiphospholipid isotypes in systemic lupus erythematosus . J Rheumatol 1988; 15: 74-9.

Kalunian KC , Peter JB , Middlekauff HR et al. Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus . Am J Med 1988; 85: 602-8.

Weir DM Handbook of Experimental Immunology, vol. I Blackwell Scientific Publications, Oxford, 1973.